October 30, 2024Open Access

Targeted microwave ablation of localised prostate cancer: Initial results of VIOLETTE trial

Key Points

Key points are not available for this paper at this time.

Abstract

These preliminary results suggest that TMA using OBT fusion is precise and safe in patients with intermediate risk localised prostate cancer. Further inclusions and follow-up are needed to assess oncological outcome.

Read Full Paperexternally

اسأل الذكاء الاصطناعي

Bookmark

View Full Paper

Cite This Study

Delongchamps et al. (Wed,) studied this question.

synapsesocial.com/papers/69dab397aae38ff6ad835e38 https://doi.org/https://doi.org/10.1002/bco2.444

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer (CLIN1001 PCM301): an open-label, phase 3, randomised controlled trial2016 · 330 citations
2Oncological and functional outcome after partial prostate HIFU ablation with Focal-One®: a prospective single-center study2021 · 26 citations
3Oncological Outcome and Value of Postoperative Magnetic Resonance Imaging after Focal High-Intensity Focused Ultrasound Therapy for Prostate Cancer2019 · 23 citations
4Oncologic and Functional Outcomes of Partial Gland Ablation with High Intensity Focused Ultrasound for Localized Prostate Cancer2018 · 79 citations
5Comparison of MR/Ultrasound Fusion–Guided Biopsy With Ultrasound-Guided Biopsy for the Diagnosis of Prostate Cancer2015 · 1,521 citations

اسأل الذكاء الاصطناعي

Bookmark

View Full Paper